Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
18 | 4 | CHEMISTRY, ANALYTICAL//TOXICOLOGY//ENVIRONMENTAL SCIENCES | 697102 |
558 | 3 | CHLORAMPHENICOL//JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS//SALINOMYCIN | 18101 |
2471 | 2 | NITAZOXANIDE//METRONIDAZOLE//NITROIMIDAZOLES | 4213 |
31174 | 1 | NITAZOXANIDE//TIZOXANIDE//HEPATOL GASTROENTEROL INFECT DIS | 171 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | NITAZOXANIDE | authKW | 6131206 | 40% | 49% | 68 |
2 | TIZOXANIDE | authKW | 1895752 | 7% | 86% | 12 |
3 | HEPATOL GASTROENTEROL INFECT DIS | address | 442336 | 4% | 40% | 6 |
4 | THIAZOLIDES | authKW | 383972 | 3% | 42% | 5 |
5 | CONFIRMATORY STAGE | authKW | 368619 | 1% | 100% | 2 |
6 | CRYPTONAZ POWDER | authKW | 368619 | 1% | 100% | 2 |
7 | INTEGRATION OF CLINICAL PHARMACOLOGY | authKW | 368619 | 1% | 100% | 2 |
8 | EXPLORATORY STAGE | authKW | 245745 | 1% | 67% | 2 |
9 | ADEN PARASITOL | address | 184310 | 1% | 100% | 1 |
10 | AVR 14 | authKW | 184310 | 1% | 100% | 1 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 634 | 36% | 0% | 62 |
2 | Chemistry, Medicinal | 422 | 15% | 0% | 26 |
3 | Tropical Medicine | 243 | 6% | 0% | 10 |
4 | Microbiology | 231 | 16% | 0% | 28 |
5 | Virology | 153 | 8% | 0% | 13 |
6 | Gastroenterology & Hepatology | 110 | 8% | 0% | 14 |
7 | Infectious Diseases | 92 | 8% | 0% | 13 |
8 | Chemistry, Analytical | 59 | 9% | 0% | 16 |
9 | Biochemical Research Methods | 58 | 7% | 0% | 12 |
10 | Parasitiology | 47 | 4% | 0% | 6 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | HEPATOL GASTROENTEROL INFECT DIS | 442336 | 4% | 40% | 6 |
2 | ADEN PARASITOL | 184310 | 1% | 100% | 1 |
3 | BACTERIOL MOL GENET | 184310 | 1% | 100% | 1 |
4 | BEHA MED | 184310 | 1% | 100% | 1 |
5 | CATEDRA CONACYTUNIDAD MERIDA | 184310 | 1% | 100% | 1 |
6 | GENE THER Y HEMATOL MALIGNANCIES STEM CELL | 184310 | 1% | 100% | 1 |
7 | HEPATOL GASTROENTEROL INFECT | 184310 | 1% | 100% | 1 |
8 | HOSP GEN ZONA MED FAMILIAR UNO | 184310 | 1% | 100% | 1 |
9 | KASR EL AINY | 184310 | 1% | 100% | 1 |
10 | LAGEAMB | 184310 | 1% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 1928 | 9% | 0% | 16 |
2 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1663 | 4% | 0% | 6 |
3 | INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1393 | 2% | 0% | 3 |
4 | ANTIVIRAL RESEARCH | 1272 | 3% | 0% | 5 |
5 | TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE | 955 | 4% | 0% | 6 |
6 | MEDICINAL CHEMISTRY | 781 | 1% | 0% | 2 |
7 | FUTURE MICROBIOLOGY | 690 | 1% | 0% | 2 |
8 | CURRENT COMPUTER-AIDED DRUG DESIGN | 509 | 1% | 0% | 1 |
9 | JOURNAL OF INFECTION AND PUBLIC HEALTH | 487 | 1% | 0% | 1 |
10 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 444 | 2% | 0% | 4 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NITAZOXANIDE | 6131206 | 40% | 49% | 68 | Search NITAZOXANIDE | Search NITAZOXANIDE |
2 | TIZOXANIDE | 1895752 | 7% | 86% | 12 | Search TIZOXANIDE | Search TIZOXANIDE |
3 | THIAZOLIDES | 383972 | 3% | 42% | 5 | Search THIAZOLIDES | Search THIAZOLIDES |
4 | CONFIRMATORY STAGE | 368619 | 1% | 100% | 2 | Search CONFIRMATORY+STAGE | Search CONFIRMATORY+STAGE |
5 | CRYPTONAZ POWDER | 368619 | 1% | 100% | 2 | Search CRYPTONAZ+POWDER | Search CRYPTONAZ+POWDER |
6 | INTEGRATION OF CLINICAL PHARMACOLOGY | 368619 | 1% | 100% | 2 | Search INTEGRATION+OF+CLINICAL+PHARMACOLOGY | Search INTEGRATION+OF+CLINICAL+PHARMACOLOGY |
7 | EXPLORATORY STAGE | 245745 | 1% | 67% | 2 | Search EXPLORATORY+STAGE | Search EXPLORATORY+STAGE |
8 | AVR 14 | 184310 | 1% | 100% | 1 | Search AVR+14 | Search AVR+14 |
9 | BLASTOCYSTIS HOMINI | 184310 | 1% | 100% | 1 | Search BLASTOCYSTIS+HOMINI | Search BLASTOCYSTIS+HOMINI |
10 | BROAD SPECTRUM ANTIVIRAL AGENTS | 184310 | 1% | 100% | 1 | Search BROAD+SPECTRUM+ANTIVIRAL+AGENTS | Search BROAD+SPECTRUM+ANTIVIRAL+AGENTS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |